Stevanato Group, an Italian company that makes glass vials for COVID-19 vaccines, is expected to conduct an initial public offering in the United States. Few details have been made public, but we'll update this page as new information emerges.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $27.42 |
|---|---|
| 52-week range | $13.68 - $36.30 |
| 50-day moving average | $32.16 |
| 200-day moving average | $25.05 |
| Wall St. target price | $33.65 |
| PE ratio | 56.4068 |
| Dividend yield | $0.054 (0.19%) |
| Earnings per share (TTM) | $0.59 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $27.42 from 2023-09-21
| 1 week (2023-09-15) | -6.64% |
|---|---|
| 1 month (2023-08-22) | -10.48% |
| 3 months (2023-06-22) | -16.56% |
| 6 months (2023-03-22) | 19.06% |
| 1 year (2022-09-22) | 54.57% |
|---|---|
| 2 years (2021-09-22) | -1.30% |
| 3 years (2020-09-18) | N/A |
| 5 years (2018-09-18) | N/A |
Valuing Stevanato Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stevanato Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
To put Stevanato Group's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 20.08% |
| Gross profit TTM | $319.8 million |
| Return on assets TTM | 7.73% |
| Return on equity TTM | 14.95% |
| Profit margin | 14.27% |
| Book value | $3.98 |
| Market Capitalization | $8.8 billion |
TTM: trailing 12 months
Dividend payout ratio: 10.14% of net profits
Recently Stevanato Group has paid out, on average, around 10.14% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stevanato Group shareholders could enjoy a 0.19% return on their shares, in the form of dividend payments. In Stevanato Group's case, that would currently equate to about $0.054 per share.
While Stevanato Group's payout ratio might seem low, this can signify that Stevanato Group is investing more in its future growth.
Stevanato Group's most recent dividend payout was on 17 July 2023. The latest dividend was paid out to all shareholders who bought their shares by 7 June 2023 (the "ex-dividend date").
Stevanato Group's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Over the last 12 months, Stevanato Group's shares have ranged in value from as little as $13.6817 up to $36.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stevanato Group's is 0.8195. This would suggest that Stevanato Group's shares are less volatile than average (for this exchange).
To put Stevanato Group's beta into context you can compare it against those of similar companies.
Stevanato Group S. p. A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.